SOLYSTAT SUSPENSION

Country: Canada

Language: English

Source: Health Canada

Buy It Now

Active ingredient:

SODIUM POLYSTYRENE SULFONATE

Available from:

PENDOPHARM DIVISION OF PHARMASCIENCE INC

ATC code:

V03AE01

INN (International Name):

POLYSTYRENE SULPHONATE

Dosage:

250MG

Pharmaceutical form:

SUSPENSION

Composition:

SODIUM POLYSTYRENE SULFONATE 250MG

Administration route:

RECTAL

Units in package:

120ML

Prescription type:

Prescription

Therapeutic area:

POTASSIUM-REMOVING AGENTS

Product summary:

Active ingredient group (AIG) number: 0108701001; AHFS:

Authorization status:

CANCELLED POST MARKET

Authorization date:

2019-07-30

Summary of Product characteristics

                                PRESCRIBING INFORMATION
PR
SOLYSTAT
®
Sodium Polystyrene Sulfonate, USP
Powder for Suspension
Oral Suspension 250 mg/mL
Rectal Suspension (Retention Enema) 250 mg/mL
CATION EXCHANGE RESIN
PENDOPHARM, DIVISION OF PHARMASCIENCE INC.
6111 Royalmount Ave., suite 100
Montréal, Québec
DATE OF REVISION:
H4P 2T4
July 23, 2014
Control #171500
®
Registered Trademark of Pharmascience Inc.
_Prescribing Information - SOLYSTAT_
_® _
Page 2 of 10
_ _
PR
SOLYSTAT
®
Sodium Polystyrene Sulfonate, USP
Powder for Suspension
Oral Suspension 250 mg/mL
Rectal Suspension (Retention Enema) 250 mg/mL
THERAPEUTIC CLASSIFICATION
Cation exchange resin
DESCRIPTION
POWDER FOR ORAL SUSPENSION
Each gram of light brown, finely ground powder contains 1 gram of
sodium polystyrene
sulfonate. The sodium content is approximately 4.1 mmol (94.3 mg) per
gram of the drug.
SOLYSTAT is a cation exchange resin prepared in the sodium phase.
Exchange capacity:
approximately 3 mmol of potassium per gram
_in vitro_
and approximately 1 mmol of potassium
per gram
_in vivo_
. SOLYSTAT
can be administered either orally or as an enema.
ORAL SUSPENSION
Each 60 mL of brown, cherry-flavored suspension contains 15 g of
sodium polystyrene sulfonate
USP and 14.1 g of sorbitol. Also contains methylparaben and
propylparaben as preservatives.
The sodium content is 65 mmol (1.5 g)/60 mL. Exchange capacity:
approximately 3 mmol of
potassium per 4 mL (per gram of resin) of suspension
_in vitro_
and approximately 1 mmol
_in vivo_
.
RETENTION ENEMA
Each 120 mL of brown suspension contains 30 g of sodium polystyrene
sulfonate USP and 28.2
g of sorbitol. Also contains methylparaben and propylparaben as
preservatives. The sodium
content is 65 mmol (1.5 g)/60 mL. Exchange capacity: approximately 3
mmol of potassium per 4
mL (per gram of resin) of suspension
_in vitro_
and approximately 1 mmol
_in vivo_
.
ACTION
Sodium polystyrene sulfonate is not absorbed from the gastrointestinal
tract. As the resin passes
through the gastrointestinal tract, the resin removes the potassium
ion
                                
                                Read the complete document
                                
                            

Documents in other languages